Hepatocellular carcinomas evolution to sorafenib resistance through hepatic leukaemia factor

Orlando Musso; Naiara Beraza

doi:10.1136/gutjnl-2019-318999

Journal Articles Gut Year : 2019

Hepatocellular carcinomas evolution to sorafenib resistance through hepatic leukaemia factor

(1) , (2)

1
2

Orlando Musso

Function : Correspondent author

Nutrition, Métabolismes et Cancer

Naiara Beraza

Function : Author

Quadram Institute

Keywords

hepatocellular carcinoma

Domains

Life Sciences [q-bio] Cancer Life Sciences [q-bio] Human health and pathology Hépatology and Gastroenterology Life Sciences [q-bio] Pharmaceutical sciences Medication

Fichier principal

1728.full.pdf (379.94 Ko)

Origin : Publication funded by an institution

Laurent Jonchère : Connect in order to contact the contributor

https://hal-univ-rennes1.archives-ouvertes.fr/hal-02179669

Submitted on : Friday, July 10, 2020-2:09:32 PM

Last modification on : Friday, March 10, 2023-4:18:30 PM

Dates and versions

hal-02179669 , version 1 (10-07-2020)

Identifiers

HAL Id : hal-02179669 , version 1
DOI : 10.1136/gutjnl-2019-318999
PUBMED : 31270163

Cite

Orlando Musso, Naiara Beraza. Hepatocellular carcinomas evolution to sorafenib resistance through hepatic leukaemia factor. Gut, 2019, 68 (10), pp.1728-1730. ⟨10.1136/gutjnl-2019-318999⟩. ⟨hal-02179669⟩

Export

BibTeX TEI Dublin Core DC Terms EndNote Datacite

Collections

INSERM UNIV-RENNES1 INRA NUMECAN NUMECAN-EXPRES UR1-UFR-SVE UNIV-RENNES UR1-BIO-SA

44 View

33 Download

Hepatocellular carcinomas evolution to sorafenib resistance through hepatic leukaemia factor

Keywords

Domains

Dates and versions

Identifiers

Cite

Export

Collections

Altmetric

Share